News
Johnson & Johnson strengthens neuroscience position with acquisition of Intra-Cellular Therapies
Johnson & Johnson has entered into a definitive agreement to acquire all outstanding shares of Intra-Cellular Therapies, a biopharmaceutical company focused on the development and...
GSK to acquire IDRx
GSK has entered into an agreement to acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of gastrointestinal...
Sarclisa obtains first approval in China for the treatment of adult patients with relapsed...
The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment...
